Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,000
NCT01882543
Efficacy and Safety of AQX-1125 in IC/BPS
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2013
Completion: Jun 30, 2015
NCT01954628
Efficacy and Safety of AQX-1125 in Unstable COPD
Start: Oct 31, 2013
Completion: Dec 31, 2015
NCT02324972
Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis
Start: Dec 31, 2014
NCT02858453
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Phase: Phase 3
Start: Jul 31, 2016
Completion: Feb 29, 2020
NCT03185195
Phase 1 Absorption Distribution Metabolism and Excretion of AQX-1125
Phase: Phase 1
Start: Nov 22, 2016
Completion: Jan 4, 2017
NCT03478020
Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study
Start: Nov 22, 2017
Completion: Apr 5, 2018
NCT03500159
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Start: Apr 18, 2018
Completion: Jul 17, 2018